1. Gromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978;42(5):2282-92.   

2. Paladugu RR, Yonemoto RH. Biologic behavior of thin malignant melanomas with regressive changes. Arch Surg 1983;118(1):41-4.   

3. McGovern VJ, Shaw HM, Milton GW. Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 1983;7(5):673-80.   

4. Trau H, Kopf AW, Rigel DS, Levine J, Rogers G, Levenstein M, Bart RS, Mintzis MM, Friedman RJ. Regression in malignant melanoma. J Am Acad Dermatol 1983;8(3):363-8.   

5. Wanebo HJ, Cooper PH, Hagar RW. Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg 1985;201(4):499-504.   

6. Cooper PH, Wanebo HJ, Hagar RW. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol 1985;121(9):1127-31.   

7. Søndergaard K, Hou-Jensen K. Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Virchows Arch A Pathol Anat Histopathol 1985;408(2-3):241-7.

8. Kelly JW, Sagebiel RW, Blois MS. Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer 1985;56(9):2287-91.   

9. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987;123(10):1326-30.   

10. Shaw HM, McCarthy WH, McCarthy SW, Milton GW. Thin malignant melanomas and recurrence potential. Arch Surg 1987;122(10):1147-50.   

11. Slingluff CL Jr, Vollmer RT, Reintgen DS, Seigler HF. Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg 1988;208(2):150-61.   

12. Shaw HM, McCarthy SW, McCarthy WH, Thompson JF, Milton GW. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology 1989;15(3):257-65.   

13. Blessing K, McLaren KM, McLean A, Davidson P. Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology 1990;17(5):389-95.   

14. Tefany FJ, Barnetson RS, Halliday GM, McCarthy SW, McCarthy WH. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol 1991;97(2):197-202.   

15. Blessing K, McLaren KM. Histological regression in primary cutaneous melanoma: recognition, prevalence and significance. Histopathology 1992;20(4):315-22.   

16. Slingluff CL Jr, Seigler HF. "Thin" malignant melanoma: risk factors and clinical management. Ann Plast Surg 1992;28(1):89-94.   

17. Park KG, Blessing K, McLaren KM, Watson AC. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis. Br J Plast Surg 1993;46(7):607-10.   

18. Halliday GM, Patel A, Hunt MJ, Tefany FJ, Barnetson RS. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg 1995;19(3):352-8.   

19. Brogelli L, Reali UM, Moretti S, Urso C. The prognostic significance of histologic regression in cutaneous melanoma. Melanoma Res 1992;2(2):87-91.   

20. Cook MG, Spatz A, Bröcker EB, Ruiter DJ. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002;197(2):188-93.   

21. Guitart J, Lowe L, Piepkorn M et al. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol 2002;138(5):603-8

22. Bernsen MR, Diepstra JH, van Mil P, Punt CJ, Figdor CG, van Muijen GN, Adema GJ, Ruiter DJ. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells. J Pathol 2004;202(1):70-9.   

23. Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol 2004;22(18):3660-7.   

24. Kaur C, Thomas RJ, Desai N, Green MA, Lovell D, Powell BW, Cook MG. The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol 2008;61(3):297-300.   

25. Cecchi R, Pavesi M, Buralli L, Innocenti S, De Gaudio C. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas. Chir Ital 2008;60(2):257-60.   

26. Ackerman AB, Cerroni L, Kerl H (eds). Pitfalls in Histologic Diagnosis of Malignant Melanoma. Philadelphia: Lea & Febiger 1994 .

27. Massi G, LeBoit. Regressing and regressed melanoma. In: Massi G, LeBoit (eds). Histological Diagnosis of Nevi and Melanoma. Darmstadt: Steinkopf Springer, 2004: 617-630.